Table 2.
Our cohort | HERMES | p | |
---|---|---|---|
onset-to-LVO | 104.4 ± 60.2/65 | 199.4 ± 87.7/632 | <0.001 |
onset-to-IVT | 120.1 ± 65.7/55 | 102.8 ± 43.1/598 | 0.007 |
onset-to-reperfusion | 272.4 ± 80.7/64 | 285.7 ± 112.9/634 | 0.3585 |
Our cohort | HERMES | p | |
---|---|---|---|
onset-to-LVO | 104.4 ± 60.2/65 | 199.4 ± 87.7/632 | <0.001 |
onset-to-IVT | 120.1 ± 65.7/55 | 102.8 ± 43.1/598 | 0.007 |
onset-to-reperfusion | 272.4 ± 80.7/64 | 285.7 ± 112.9/634 | 0.3585 |